118 related articles for article (PubMed ID: 23230145)
41. Negative regulation of YAP by LATS1 underscores evolutionary conservation of the Drosophila Hippo pathway.
Zhang J; Smolen GA; Haber DA
Cancer Res; 2008 Apr; 68(8):2789-94. PubMed ID: 18413746
[TBL] [Abstract][Full Text] [Related]
42. Liquid-Liquid Phase Separation of DDR1 Counteracts the Hippo Pathway to Orchestrate Arterial Stiffening.
Liu J; Wang J; Liu Y; Xie SA; Zhang J; Zhao C; Zhou Y; Pang W; Yao W; Peng Q; Wang X; Zhou J
Circ Res; 2023 Jan; 132(1):87-105. PubMed ID: 36475898
[TBL] [Abstract][Full Text] [Related]
43. Transcriptional activation of the Lats1 tumor suppressor gene in tumors of CUX1 transgenic mice.
Siam R; Harada R; Cadieux C; Battat R; Vadnais C; Nepveu A
Mol Cancer; 2009 Aug; 8():60. PubMed ID: 19656388
[TBL] [Abstract][Full Text] [Related]
44. LATS1 K751 acetylation blocks activation of Hippo signalling and switches LATS1 from a tumor suppressor to an oncoprotein.
Yang S; Xu W; Liu C; Jin J; Li X; Jiang Y; Zhang L; Meng X; Zhan J; Zhang H
Sci China Life Sci; 2022 Jan; 65(1):129-141. PubMed ID: 33945069
[TBL] [Abstract][Full Text] [Related]
45. LATS1 suppresses proliferation and invasion of cervical cancer.
Deng J; Zhang W; Liu S; An H; Tan L; Ma L
Mol Med Rep; 2017 Apr; 15(4):1654-1660. PubMed ID: 28259899
[TBL] [Abstract][Full Text] [Related]
46. TAF4 inactivation reveals the 3 dimensional growth promoting activities of collagen 6A3.
Martianov I; Cler E; Duluc I; Vicaire S; Philipps M; Freund JN; Davidson I
PLoS One; 2014; 9(2):e87365. PubMed ID: 24498316
[TBL] [Abstract][Full Text] [Related]
47. SUMOylation activates large tumour suppressor 1 to maintain the tissue homeostasis during Hippo signalling.
Mei L; Qv M; Bao H; He Q; Xu Y; Zhang Q; Shi W; Ren Q; Yan Z; Xu C; Tang C; Hussain M; Zeng LH; Wu X
Oncogene; 2021 Sep; 40(35):5357-5366. PubMed ID: 34267330
[TBL] [Abstract][Full Text] [Related]
48. Generation of a serine/threonine-protein kinase LATS1 gene-edited iPSC MUSIi012-A-3.
Lorthongpanich C; Laowtammathron C; Jiamvoraphong N; Srisook P; Chingsuwanrote P; Klaihmon P; Waeteekul S; U-Pratya Y; Issaragrisil S
Stem Cell Res; 2020 Oct; 48():101950. PubMed ID: 32791482
[TBL] [Abstract][Full Text] [Related]
49. Expression of large tumour suppressor (LATS) kinases modulates chemotherapy response in advanced non-small cell lung cancer.
Luo SY; Kwok HH; Yang PC; Ip MS; Minna JD; Lam DC
Transl Lung Cancer Res; 2020 Apr; 9(2):294-305. PubMed ID: 32420069
[TBL] [Abstract][Full Text] [Related]
50. Mutation analysis of large tumor suppressor genes LATS1 and LATS2 supports a tumor suppressor role in human cancer.
Yu T; Bachman J; Lai ZC
Protein Cell; 2015 Jan; 6(1):6-11. PubMed ID: 25482410
[TBL] [Abstract][Full Text] [Related]
51. A single copy of large tumor suppressor 1 or large tumor suppressor 2 is sufficient for normal hematopoiesis.
Li ZG; Fu XM; Chai CY; Sun FF; Xiao FF; Huang YX; Yao K; Chen JP; Hou Y
Chin Med J (Engl); 2020 Aug; 133(16):1943-1951. PubMed ID: 32826458
[TBL] [Abstract][Full Text] [Related]
52. Structural basis for autoinhibition and its relief of MOB1 in the Hippo pathway.
Kim SY; Tachioka Y; Mori T; Hakoshima T
Sci Rep; 2016 Jun; 6():28488. PubMed ID: 27335147
[TBL] [Abstract][Full Text] [Related]
53. A phosphatidic acid-binding lncRNA SNHG9 facilitates LATS1 liquid-liquid phase separation to promote oncogenic YAP signaling.
Li RH; Tian T; Ge QW; He XY; Shi CY; Li JH; Zhang Z; Liu FZ; Sang LJ; Yang ZZ; Liu YZ; Xiong Y; Yan Q; Li X; Ju HQ; Liu J; Wang LJ; Shao JZ; Wang W; Zhou T; Lin A
Cell Res; 2021 Oct; 31(10):1088-1105. PubMed ID: 34267352
[TBL] [Abstract][Full Text] [Related]
54. Mst out and HCC in.
Zhao B; Lei Q; Guan KL
Cancer Cell; 2009 Nov; 16(5):363-4. PubMed ID: 19878866
[TBL] [Abstract][Full Text] [Related]
55. Low‑frequency ultrasound and microbubbles combined with simvastatin promote the apoptosis of MCF‑7 cells by affecting the LATS1/YAP/RHAMM pathway.
Li H; Chen C; Wang D
Mol Med Rep; 2018 Sep; 18(3):2724-2732. PubMed ID: 30015955
[TBL] [Abstract][Full Text] [Related]
56. Inactivation of LATS1/2 drives luminal-basal plasticity to initiate basal-like mammary carcinomas.
Kern JG; Tilston-Lunel AM; Federico A; Ning B; Mueller A; Peppler GB; Stampouloglou E; Cheng N; Johnson RL; Lenburg ME; Beane JE; Monti S; Varelas X
Nat Commun; 2022 Nov; 13(1):7198. PubMed ID: 36443313
[TBL] [Abstract][Full Text] [Related]
57. Skeletal muscle phenotyping of Hippo gene-mutated mice reveals that Lats1 deletion increases the percentage of type I muscle fibers.
Nezhad FY; Riermeier A; Schönfelder M; Becker L; de Angelis MH; Wackerhage H
Transgenic Res; 2022 Apr; 31(2):227-237. PubMed ID: 34984591
[TBL] [Abstract][Full Text] [Related]
58. A crucial role of WW45 in developing epithelial tissues in the mouse.
Lee JH; Kim TS; Yang TH; Koo BK; Oh SP; Lee KP; Oh HJ; Lee SH; Kong YY; Kim JM; Lim DS
EMBO J; 2008 Apr; 27(8):1231-42. PubMed ID: 18369314
[TBL] [Abstract][Full Text] [Related]
59. The clinicopathological and prognostic significances of LATS1 expression in breast cancer.
Zheng HC; Xiang LW; Cui ZG; Xue H; E Y; Zhao MZ
Histol Histopathol; 2022 Jul; 37(7):665-677. PubMed ID: 35142365
[TBL] [Abstract][Full Text] [Related]
60. An N-terminal truncated carboxypeptidase E splice isoform induces tumor growth and is a biomarker for predicting future metastasis in human cancers.
Lee TK; Murthy SR; Cawley NX; Dhanvantari S; Hewitt SM; Lou H; Lau T; Ma S; Huynh T; Wesley RA; Ng IO; Pacak K; Poon RT; Loh YP
J Clin Invest; 2011 Mar; 121(3):880-92. PubMed ID: 21285511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
